1Management of acute coronary syndromes:acute coronary syndromes without persistent ST segment elevation.Recommendations of the Task Force of the European Society of Cardiology.Eur Heart J 2000,21:1406-1432.
2ACC/AHA Guidejines for the management of patients with unstable angina and non-ST-segment elevation myocardial in farction:Executive Summary and Recommendations.Circulation 2000,102:1193-1209.
3Coben M,Demers C,Gurfinkel EP,et al.A Comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease.Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events Study Group.N Engl J Med 1997,337(7):447-452.
4Antman EM,McCabe CH,Gurfinkel EP,et al.Encoxaparin prevents death and cardiac ischaemic events in unstable angina/Non-Q-wave myocardial infarction.Results of the Thrombolysis in Myocardial Infarction(TIMI)11B trial.Circulation 1999,100:1593-1601.
5Platelet Receptor Inhibition in Ischemic Syndromes Management(PRISM)Study Investigators.A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.N Engl J Med 1998,338:1498-1505.
6PRISM-PLUS Study Investigators.Inhibition of the platelet glycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM PLUS).N Engl J Med 1998,21:338:1488-97.
7The PURSUIT Investigators Trial.Platelet Glycoprotein Ⅱb/Ⅲa in Unstable Angina Receptor Suppression using Integrilin Thetapy.N Engl J Med 1998,339:436-443.
8Fuster V,Badimon L.Badimon JJ,et al.The pathogenesis of coronary artery disease and the acute coronary syndromes.N Engl J Med 1992,336:242-250.
9Hirsh J.Fuster V.guide to antlcoagulant therapy.Part J:Heparin.American Heart Association.Circulation 1994,89:1449-1468.
10Samama MM,Bara L.Gerotziafas GT.Mechanisms for the antithrombotic activity in man of the low molecular Weight heparins.Hemostasis 1994,24:105-117.
7Harada K,Grossman W.Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts[J].J Clin Invest,1994,94:623.
8Banai S,Jaklitsch M T,Shou M,et al.Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs[J].Circulation,1994,89:2183.
